Holder of the David Weatherall Chair of Medicine and the National Health Service (NHS) Chair of Pharmacogenetics at the University of Liverpool, UK; Professor of Molecular and Clinical Pharmacology; Director of the MRC Centre for Drug Safety and the Wolfson Centre for Personalized Medicine in Liverpool, UK
Advisor and former Secretary General of the European Patients' Forum; expert in policy and advocacy for patient empowerment, access to healthcare, and patient participation; founding partner of Millwater Partners GmbH
Managing Director of the Wyss Center for Bio and Neuroengineering; Professor of Medicine, Pharmacology and Systems Therapeutics at the Icahn School of Medicine, Mount Sinai, New York, USA
Professor of Molecular Oncology; Immunologist and Cancer Researcher; Research Director at the Agency for Science, Technology and Research (A*STAR) in Singapore; Professor of Tumor Suppressor Biology at the Karolinska Institute, Stockholm
Professor at the Institute of Biochemistry and Molecular Biology at the University of Southern Denmark; Director of the Center of Excellence in Functional Genomics and Tissue Plasticity (ATLAS) and the Center for Adipocyte Signaling (ADIPOSIGN)
Dean of Karolinska Institutet Nord; Coordinator for Science and Society in the President's Office; Head of the Department of Learning, Informatics, Management and Ethics; Professor in the Department of Physiology and Pharmacology at Karolinska Institutet
Board of Trustees and Shareholders
Impressions from the Annual General Meeting of the Robert Bosch Stiftung.